SynaptaGenX™

SynaptaGenX

SynaptaGenX™ is a patented KB220z neuroadaptagen that provides greatly accelerated absorption by the body for optimal brain health, enhanced energy, reduced stress as well as helping nutritional maintenance of overall mood, health and a sense of well-being.

 

Please note that Synaptamine, an earlier liquid manifestation of SynaptaGenX, now has been replaced by SynaptaGenX, which also uses the patented KB220z neuroadaptagen formula but it is a tablet instead of liquid.

 

For more information: synaptagenx.com

For purchase:   nupathways.com/synaptagenx-3

 

 

See also:

Reward Deficiency Syndrome

.

SynaptaGenX

SynaptaGenX is a patented neuroadaptagen that provides greatly accelerated absorption by the body. A “neuroadaptagen: is a natural substance considered to help the nervous system adapt to stress and to exert a normalizing effect upon bodily processes. As a neuroadaptagen, SynaptaGenX is recommended for optimal brain health, enhanced energy, reduced stress as well as helping nutritional maintenance of overall mood, health, and a sense of well-being.

 

Who should consider taking SynaptaGenX?

SynaptaGenX is prescribed as part of a balanced program of treatment directed at stabilizing brain chemistry related to Reward Deficiency Syndrome (RDS). RDS is a condition characterized by low or inadequate levels of dopamine, a neurotransmitter, in the midbrain. Dopamine levels may be low as a result of acquired conditions due to high levels of stress, chronic pain or depression. There is growing research that indicates Synaptamine may be helpful in chronic pain, including fibromyalgia.

 

Low dopamine levels may be genetically driven due to variants in a person’s DNA that make it difficult for a person to maintain “optimal” levels of dopamine. It is believed that many medical conditions are associated with an underlying dopamine deficiency/insufficiency including ADD, OCD, fibromyalgia, PTSD, and certain anger disorders as well as chemical addictions and behavioral addictions such as gambling and binge eating. If you have a family history of any of these RDS conditions, you may be at increased risk for suboptimal dopamine. Your physician can perform genetic tests that may indicate predisposition to RDS which may predict your potential to respond to Synaptamine.

 

SynaptaGenX is particularly helpful in reducing cravings associated with chemical withdrawals such as quitting smoking, or withdrawing from alcohol or opioids, including tapering off buprenorphins (Suboxone, Zubolv, Bunavail). SynaptaGenX is currently under study as a stand-alone treatment for acute opioid withdrawal. It has also been shown to reduce the cravings associated with addictive eating behaviors and binge eating.

 

Dosing SynaptaGenX

When advised to take SynaptaGenX, please following dosing instructions provided by your physician. It  should be taken on an empty stomach, at least one hour before a meal or two hours after a meal.The usual dose is two tablets twice a day. SynaptaGenX is a proprietary blend of natural substances and is rarely associated with any side effects which, when they do occur, are very mild and transient. It is non-addictive.

 

SynaptaGenX product information:

 

For more information:

Additional information including access to research publications can also be obtained online at:

synaptagenx.com

For purchase:

nupathways.com/synaptagenx-3

  

 

References:

SynaptaGenX – Overviews of KB220 Variants

  1. Synaptamine – brief summary
  2. Can the chronic administration of the combination of buprenorphine and naloxone block dopaminergic activity causing anti-reward and relapse potential? – 2011
  3. Addiction Treatment in America – After Money or Aftercare? – 2015
  4. Should the United States Government Repeal Restrictions on Buprenorphine:Naloxone Treatment? – 2016
  5. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry
  6. Gene–Dairy Food Interactions and Health Outcomes – A Review of Nutrigenetic Studies – 2017
  7. Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse – 2018

 

Genetic Testing – GARS & Reward Deficiency Syndrome

  1. Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder – Unlocking the Mysteries of Resilience and Vulnerability – 2010
  2. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS) – Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms – 2012
  3. Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases? – 2014
  4. Genetic Addiction Risk Score (GARS) – Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS) – 2014
  5. Can Genetic Testing Provide Information to Develop Customized Nutrigenomic Solutions for Reward Deficiency Syndrome? – 2015
  6. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS) – Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms – 2015
  7. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome – A Pictorial – 2016
  8. GLOBAL OPIOID EPIDEMIC – DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM™) – LESSONS LEARNED FROM AMERICA – 2017
  9. THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCUITRY AND REDUCE ADDICTIVE BEHAVIORS – 2017
  10. Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD) – 2017
  11. The Benefits of Genetic Addiction Risk Score (GARS™) Testing in Substance Use Disorder (SUD) – 2018
  12. Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis – 2018

Genetic Testing – GARS & Carbohydrate Addiction

  1. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS) – Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms – 2015

Genetic Testing – GARS & PTSD

  1. Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder – Unlocking the Mysteries of Resilience and Vulnerability – 2010

Genetic Testing – GARS & Pain

  1. Can Genetic Testing Coupled with Enhanced Dopaminergic Activation Reduce Recidivism Rates in the Workers Compensation Legacy Cases? – 2014

Genetic Testing – GARS & Substance Use Disorders

  1. GLOBAL OPIOID EPIDEMIC – DOOMED TO FAIL WITHOUT GENETICALLY BASED PRECISION ADDICTION MEDICINE (PAM™) – LESSONS LEARNED FROM AMERICA – 2017
  2. THE BENEFITS OF CUSTOMIZED DNA DIRECTED NUTRITION TO BALANCE THE BRAIN REWARD CIRCU
    ITRY AND REDUCE ADDICTIVE BEHAVIORS – 2017
  3. Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD) – 2017
  4. The Benefits of Genetic Addiction Risk Score (GARS™) Testing in Substance Use Disorder (SUD) – 2018
  5. Promoting Precision Addiction Management (PAM) to Combat the Global Opioid Crisis – 2018

SynaptaGenX – Addiction

See: CAM Treatment of Addiction Recovery

 

SynaptaGenX – Buprenorphine

  1. Withdrawal from Buprenorphine:Naloxone and Maintenance with a Natural Dopaminergic Agonist – A Cautionary Note

 

SynaptaGenX – Chronic Pain

  1. Nucleus accumbens dopaminergic neurotransmission switches its modulatory action in chronification of inflammatory hyperalgesia – 2015

SynaptaGenX – Fibromyalgia

  1. A Multi-Locus Approach to Treating Fibromyalgia by Boosting Dopaminergic Activity in the Meso-Limbic System of the Brain

 

SynaptaGenX – Lucid Dreams

  1. Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients – Role of enhanced brain reward functional connectivity and homeostasis redeeming joy – 2015
  2. Using the Neuroadaptagen KB200zTM to Ameliorate Terrifying, Lucid Nightmares in RDS Patients – the Role of Enhanced, Brain- Reward, Functional Connectivity and Dopaminergic Homeostasis – 2015
  3. KB220Z™ a Pro-Dopamine Regulator Associated with the Protracted, Alleviation of Terrifying Lucid Dreams. Can We Infer Neuroplasticity-induced Changes in the Reward Circuit? – 2016

SynaptaGenX – PTSD

  1. Putative dopamine agonist (KB220Z) attenuates lucid nightmares in PTSD patients – Role of enhanced brain reward functional connectivity and homeostasis redeeming joy – 2015
  2. Diagnosis and Healing In Veterans Suspected of Suffering from Post-Traumatic Stress Disorder (PTSD) Using Reward Gene Testing and RewardCircuitry Natural Dopaminergic Activation-2012

SynaptaGenX – Sleep

  1. hypothesizing-that-putative-dopaminergic-melatonin-benzodiazepine-reward-circuitry-receptors – 2013

Emphasis on Education

 

Accurate Clinic promotes patient education as the foundation of it’s medical care. In Dr. Ehlenberger’s integrative approach to patient care, including conventional and complementary and alternative medical (CAM) treatments, he may encourage or provide advice about the use of supplements. However, the specifics of choice of supplement, dosing and duration of treatment should be individualized through discussion with Dr. Ehlenberger. The following information and reference articles are presented to provide the reader with some of the latest research to facilitate evidence-based, informed decisions regarding the use of conventional as well as CAM treatments.

 

For medical-legal reasons, access to these links is limited to patients enrolled in an Accurate Clinic medical program.

 

Should you wish more information regarding any of the subjects listed – or not listed –  here, please contact Dr. Ehlenberger. He has literally thousands of published articles to share on hundreds of topics associated with pain management, weight loss, nutrition, addiction recovery and emergency medicine. It would take years for you to read them, as it did him.

 

For more information, please contact Accurate Clinic.

 

Supplements recommended by Dr. Ehlenberger may be purchased commercially online or at Accurate Clinic.

Please read about
our statem
ent regarding the sale of products recommended by Dr. Ehlenberger.

Accurate Supplement Prices

 

 

.